Trials / Completed
CompletedNCT00560014
Nutrient Levels Alter Transplant Outcome
Role of Immunonutrient Levels in Preventing Complications After Renal Transplantation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- University of Cincinnati · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to look at lipid profiles of plasma and RBC and amino acid profiles in plasma to determine if they are associated with allograft rejection, calcineurin inhibitor toxicity or new onset diabetes mellitus in renal transplant patients receiving dietary supplements with arginine and omega-3 fatty acids.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Arginine and canola oil | Canola oil 1 tablespoon BID Arginine 9.0grams BID |
| DIETARY_SUPPLEMENT | Coromega and Arginine | Arginine 9.0 grams BID Coromega dose based on weight |
Timeline
- Start date
- 1997-09-01
- Completion
- 2005-05-01
- First posted
- 2007-11-19
- Last updated
- 2007-11-19
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00560014. Inclusion in this directory is not an endorsement.